Visual TL;DR
Fragmented AI EffortsDriver
each FDA center operated its own AI capabilities, leading to duplicated costs
From the article 2 mentionsThis initiative, underpinned by a governed data foundation called Halo running on Databricks, aimed to unify fragmented AI efforts across the agency's eight distinct regulatory centers.
ELSA AI PlatformCore
FDA launched ELSA, an enterprise AI platform, to unify fragmented efforts
From the article 4 mentionsFood and Drug Administration (FDA) has achieved remarkable adoption of its new AI platform, ELSA, with 85% of its 16,000 staff using it daily within two months of launch.
Halo Data FoundationCore
From the article 2 mentionsThis initiative, underpinned by a governed data foundation called Halo running on Databricks, aimed to unify fragmented AI efforts across the agency's eight distinct regulatory centers.
Custom AI AgentsEffect
platform enables staff to create custom AI agents for specific tasks
From the article 2 mentionsFDA medical doctors, scientists, and administrative staff are now independently building custom AI agents.
Unified Data AccessEffect
brought 50 to 60 data sources from all centers onto a single platform
From the article 2 mentionsPreviously, each FDA center operated its own AI capabilities, leading to duplicated costs and a lack of unified data access.
Improved Data SharingEffect
From the articleData sharing improved dramatically, shifting from multi-day processes to near real-time streaming.
85% Staff AdoptionOutcome
From the article 3 mentionsFood and Drug Administration (FDA) has achieved remarkable adoption of its new AI platform, ELSA, with 85% of its 16,000 staff using it daily within two months of launch.
